August 24, 2026 - 01:55

Marvell Technology saw its stock climb 6.8 percent in recent trading after the company revealed a broader custom artificial intelligence chip deal with Alphabet's Google. The updated agreement covers AI inference accelerators, storage controllers, and network interface hardware, deepening the relationship between the two firms.
A notable part of the arrangement involves a warrant that gives Google the right to acquire up to roughly 7 percent of Marvell's outstanding shares. That warrant becomes exercisable as Google reaches multi-billion dollar purchase milestones tied to the chip supply. The structure ties Google's long-term AI infrastructure spending directly to Marvell's revenue pipeline, while also giving Google a gradual equity stake in the chip designer.
Investors responded positively to the news, seeing it as a strong signal of sustained demand for Marvell's custom silicon work. The company has positioned itself as a key player in the AI hardware space, competing with larger rivals by offering tailored solutions for hyperscale data center operators.
The deal also highlights how major cloud providers are locking in supply and design partnerships early, given the tight market for advanced chips. For Marvell, the arrangement provides both financial visibility and a strategic backer with deep pockets. The stock move suggests the market views this as more than just a routine supply contract, but rather a vote of confidence in Marvell's technology roadmap and execution capability.
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...
September 27, 2026 - 08:32
New Biochip Enables Real-Time Tracking of Parkinson's Treatment ResponseResearchers have created a biochip technology that allows for real-time monitoring of how Parkinson`s disease patients respond to treatment. The development comes from a team working on advanced...